{"member_organisations": "", "identification_number": "196359321438-80", "fields_of_interest": "International co-operation and development, Employment and Social Affairs, Business and Industry, Environment, Regional Policy, Research and innovation, Trans-European Networks, Public Health", "head_office_address": "Becton, Dickinson and Company 1 Becton Drive Franklin Lakes, New Jersey 07417-1880", "full_time_equivalent_fte": "0,5", "person_with_legal_responsibility": "Roland Goette", "financial_year_start_date": "01/10/2016", "grants": "", "country_code": "US", "head_office_country": "United States", "eu_initiatives": "Patient Safety, including HAI's, AMR and medication management. \nOccupational safety and health of healthcare staff. \nHealthcare efficiency. \nMedical Devices and IVD's Regulation. \nEnvironmental safety and regulation, including REACH and the RoHS. \nEU Public Procurement Directive. \nThe Cross Border Health Directive. \nHTA Network. \ne-health. \nHealth screening and early diagnosis. \nWomen's health and cancer. \nDiabetes. \nHealth research", "level_of_interest": "global", "organisation_name": "Becton Dickinson (BD)", "belgium_office_post_code": "9320 EREMBODEGEM", "procurement": "", "section": "II - In-house lobbyists and trade/business/professional associations", "lon": -74.20857769999999, "source": "", "belgium_office_address": "BD Benelux N.V. Erembodegem-Dorp 86", "belgium_office_phone": "(+32)53 720 211", "number_of_ep_accredited_persons": "", "overall_budget_turnover_as_a_range": "", "subsection": "Companies & groups", "no_geo_reference": true, "persons_accredited_for_access_to_european_parliament_premises": "", "estimate_of_costs_absolute_amount": "", "registration_date": "19/04/2016", "website_address": "http://www.bd.com/", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "New Jersey", "membership": "MedTech Europe \nEucomed  \nEDMA \nAlliance for  Safe on Line Pharmacy  \nEuropean Alliance for Access to Safe Medicines \nInternational Federation of Pharmaceutical Manufacturers & Associations : Aantimicrobial Resistane Project", "head_office_post_code": "NJ 07417-188", "goals__remit": "BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance cellular studies and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, optimize respiratory care and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 45,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health.", "industry_forums": "", "inter_groups": "", "number_of_persons_involved": "1", "relevant_communication": "Support of relevant activities undertaken by MedTech Europe (Eucomed and EDMA) \nSupport of the following activities: \nProtection of healthcare workers from hazardous drugs exposure risks. Madrid Regional Regulation presentation in the European Parliament \nSurgical Site Infections and the importance of appropriate skin antisepsis : Public Policy Recomendations document developed by experts and presented in the European Parliament  \nGlobal Sepsis Alliance meeting in Brussels presenting the  European Sepsis Alliance organization \nThe role of rapid diagnostics in AMR prevention:policy  document developed by experts and presented in the European Parliament  \nMDR and safety clauses interpretation: round table discussion  among stakeholders in the European Parliament", "financial_year_end_date": "01/09/2017", "lat": 41.0163291, "estimate_of_costs_as_a_range": "400000-499999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "Corporation", "person_in_charge_of_eu_relations": "Jose Luis Gomez", "customers": "", "belgium_office_post_box": "", "position": "VP, Public Policy and Advocacy Europe", "belgium_office_city": "Erembodegem", "head_office_phone": "(+1)2018476800"}